| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |